Pet Care and Wellness

This living topic covers a wide range of important issues related to pet health and wellness, offering valuable insights for pet owners. It includes advancements in veterinary technology like AI for detecting heart murmurs in dogs, the importance of dental hygiene for pets, and emergency first aid techniques. It also discusses the impact of pet ownership on mental health, the risks of over-the-counter flea and tick treatments, and the spread of bird flu. Additionally, it highlights the benefits and drawbacks of pet insurance and wellness plans, the use of telehealth for veterinary services, preventing heat stroke in dogs, and understanding the stress levels in dogs related to their owners' behavior. Overall, the content provides comprehensive guidance on maintaining the health and well-being of pets.

Latest

How to handle your pets' fireworks anxiety

Having a plan in place ahead of 4th of July can help ease your pets’ – and your – stress

Featured Pet News photo

Fourth of July is prime time for fireworks, and the loud sounds can be a trigger of stress and anxiety for your pets. 

There are several ways for pet owners to manage their pets’ anxiety, including prescription medication, natural supplements, white noise, and more. 

The best way to ensure your pet is comfortable during fireworks is to have a plan in place ahead of time. 

Fourth of July is right around the corner, and while many consumers are preparing for barbecues and tri...

Read Article
Featured Pet News photo

Article Timeline

Newest
  • Newest
  • Oldest
2025
2024
Article Image

FDA cautions veterinarians about prescribing Librela for dogs

The U.S. Food and Drug Administration has warned veterinarians that an often-prescribed arthritis medication for dogs may be harmful.

In a cautionary letter, the agency said it had completed an evaluation of adverse events reported in dogs of various ages treated with Librela, an injected drug with the generic name bedinvetmab.

“The adverse events identified and analyzed include: ataxia, seizures, other neurologic signs, including but not limited to, paresis, recumbency, urinary incontinence; polyuria, and polydipsia,” the FDA said in the letter. 

It said that in some cases, death was reported as an outcome of these adverse events. 

The FDA approved Librela, a monoclonal antibody drug used for the control of pain associated with osteoarthritis in dogs, in 2023, and it was introduced to the marketplace later that year. 

Prior to approval, the FDA reviewed available studies and other data on Librela and determined Librela to be safe and effective for its intended use for control of pain associated with osteoarthritis in dogs. Librela is dosed by weight and labeled for subcutaneous injection once a month. 

The FDA advised veterinarians to report any adverse effects of the drug to Zoetis, the drug manufacturer. 

The U.S. Food and Drug Administration has warned veterinarians that an often-prescribed arthritis medication for dogs may be harmful.In a cautionary le...